Bioactivity:

Abeprazan (DWP14012) is a potassium-competitive acid blocker and it is developed as a potential alternative to proton pump inhibitor for the treatment of acid-related diseases[1]. Abeprazan inhibits H+, K+- ATPase by reversible potassium-competitive ionic

CAS nr:

1902954-60-2

Purity:

98%

Molecular Weight:

410,41

SMILES:

CNCC1=CN(S(=O)(C2=CC=CC(F)=C2)=O)C(C3=CC=C(F)C=C3F)=C1OC

Formula:

C19H17F3N2O3S

Pathway:

Others

Target:

Others